FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Cannbis

  • Home
  •  | 
  • Tag Archives: "Cannbis"

Invictus Closes $25.5 Million Debt Financing from ATB Financial

Invictus Closes $25.5 Million Debt Financing from ATB Financial
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has closed the previously disclosed $25.5 million debt financing arrangement (the "Financing") with ATB Financial ("ATB") (see press release dated August 8, 2018, for further details). The Financing will be used to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities (the "Expansion Plan") at Acreage Pharms Ltd. ("Acreage Pharms"), located in West-Central Alberta. The Expansion Plan will add a total of 180,000 square feet of production capacity to Acreage Pharms. The 90,000 square foot Phase 3 expansion is well underway with over $6 million in progress payments already made for permitting, lot preparation, foundation construction and precast installation. Phase 3 has a target completion date of January 2019 with Phase 4 expected to be completed later in 2019.
Read more

The Needle Capital Corp. Enters into Agreement with The Flowr Corporation to Complete Business Combination and Concurrent Financing Transactions

The Needle Capital Corp. Enters into Agreement with The Flowr Corporation to Complete Business Combination and Concurrent Financing Transactions
The Needle Capital Corp. (TSXV:NEDL.P) (“Needle” or the “Company”), a capital pool company as defined under Policy 2.4 – Capital Pool Companies (“CPC”) of the TSX Venture Exchange (the “Exchange”), is pleased to announce it has entered into a business combination agreement dated August 27, 2018 (the “Agreement”) with The Flowr Corporation (“Flowr”) whereby Needle and Flowr will effect a transaction that will result in a reverse takeover of Needle by the shareholders of Flowr (the “Transaction”) to ultimately form the resulting issuer (the “Resulting Issuer”). Upon completion of the Transaction, it is the intention of the parties that the Resulting Issuer  will continue the business of Flowr subject to the terms and conditions outlined below. Needle intends that the Transaction will constitute its Qualifying Transaction, as such term is defined in Policy 2.4 of the Exchange.  In addition, the Transaction constitutes a "Non-Arm's Length Qualifying Transaction" as defined in Policy 1.1 of the Exchange.
Read more

POCML 4 Inc. Executes Definitive Agreement With MediPharm Labs Inc.

POCML 4 Inc. Executes Definitive Agreement With MediPharm Labs Inc.
POCML 4 Inc. (TSXV:POCM) (“POCML”) is pleased to announce that it has entered into a definitive agreement with MediPharm Labs Inc. (“MediPharm”). MediPharm is a medicinal cannabis company specializing in the pharmaceutical production of oil products as a licensed producer by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and is the first company in Canada to become a licensed producer for cannabis oil production without first receiving a cannabis cultivation licence.
Read more